ArticleJournal of lipid research2022

Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses.

Dorina Ibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.